BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17728268)

  • 1. Re: "Multiparameter calibration of a natural history model of cervical cancer".
    Basu S; Galvani AP
    Am J Epidemiol; 2007 Oct; 166(8):983; author reply 983-4. PubMed ID: 17728268
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE; Unger ER; Saraiya M
    J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
    [No Abstract]   [Full Text] [Related]  

  • 3. Human papillomavirus genotype distributions inform screening and vaccination policy.
    Pinkowish MD
    CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
    [No Abstract]   [Full Text] [Related]  

  • 4. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.
    Giuliano AR; Salmon D
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):805-8. PubMed ID: 18398020
    [No Abstract]   [Full Text] [Related]  

  • 5. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
    Brotherton JM
    Vaccine; 2008 Jan; 26(2):250-6. PubMed ID: 18068276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US.
    Saraiya M; Ahmed F; White M; Lawson H; Unger ER; Eheman C
    Cancer; 2008 Nov; 113(10 Suppl):2837-40. PubMed ID: 18980202
    [No Abstract]   [Full Text] [Related]  

  • 7. The economic impact of HPV vaccines: not just cervical cancer.
    Myers ER
    Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522
    [No Abstract]   [Full Text] [Related]  

  • 8. HPV induced triple neoplasms: a case report.
    Visconti V; Antonilli M; Bellati F; Napoletano C; French D; Benedetti Panici P; Nuti M
    Am J Obstet Gynecol; 2009 Aug; 201(2):e9-e12. PubMed ID: 19646562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
    Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
    Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current acceptance of the HPV vaccine.
    Miller MM; Wilson JM; Waldrop J
    Nurse Pract; 2008 Apr; 33(4):18-22; quiz 22-3. PubMed ID: 18388548
    [No Abstract]   [Full Text] [Related]  

  • 11. Bandicoots, bonobos, and boys: papillomavirus and vaccination strategies.
    Grose C
    Pediatrics; 2009 Apr; 123(4):1244-5. PubMed ID: 19336384
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic HPV vaccination for the prevention of cervical cancer.
    Hernandez BY
    Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural history and epidemiology of HPV infection and cervical cancer.
    Castellsagué X
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening.
    Ralston Howe E; Li Z; McGlennen RC; Hellerstedt WL; Downs LS
    Am J Obstet Gynecol; 2009 Mar; 200(3):245.e1-7. PubMed ID: 19254582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
    Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mucosotropic papillomavirus genotypes in the Italian population].
    Duraturo ML; Tornesello ML; Buonaguro L; Buonaguro FM
    Minerva Ginecol; 2007 Oct; 59(5):553-5. PubMed ID: 17912182
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implementation of HPV vaccination in Germany].
    Schreckenberger C; Kaufmann AM; Schneider A
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV and cervical cancer in the 2007 report.
    WHO/ICO Information Centre on HPV and Cervical Cancer
    Vaccine; 2007 Nov; 25 Suppl 3():C1-230. PubMed ID: 18068032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.